Cadaver-Skin Booster Aims to Reset Facial Aging
A new anti-aging injectable, Elravie Re2O, uses donor skin stripped of cells to form a preserved extracellular matrix that acts as a scaffold for the skin to regenerate, potentially reducing fine lines and refining pores. Not FDA-approved in the US, but already available in Korea and other markets and offered by some clinics in the US; the company hopes to launch in the US by 2027. While some patients report noticeable improvements, critics flag ethical concerns about tissue use and long‑term safety and durability remain uncertain.